Evidence map›Paper›PMID 17301049›Full record

ArticleThe Journal of biological chemistry2007

Tests of the extension and deadbolt models of integrin activation.

Jieqing Zhu, Brian Boylan, Bing-Hao Luo, Peter J Newman, Timothy A Springer

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Prediction of αBiophysical journal · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Data-driven prediction of αBiophysical journal · 2024
    Article
  6. Article
  7. β2 integrin activation and signal transduction in leukocyte recruitment.American journal of physiology. Cell physiology · 2021
    Review
  8. Article
  9. Review
  10. Autonomous conformational regulation of βProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Article
  12. Review
  13. The importance of N-glycosylation on βScientific reports · 2017
    Article
  14. Tension in Cancer.International journal of molecular sciences · 2016
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Complete integrin headpiece opening in eight steps.The Journal of cell biology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jieqing ZhuThe CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts 02115, USA.
Brian Boylan
Bing-Hao Luo
Peter J Newman
Timothy A Springer

Funding

Transgenic/Knockout CoreP01HL044612 · NHLBI · VERSITI WISCONSIN, INC. · PI NEWMAN, PETER J · 1990 to 2015
$33.4M
STRUCTURE OF INTEGRINS AND YWTD BETA PROPELLER DOMAINSP01HL048675 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI SPRINGER, TIMOTHY A · 1992 to 2009
$20.9M
NHLBI NIH HHS HL44612NHLBI NIH HHS HL48675NHLBI NIH HHS P01 HL044612NHLBI NIH HHS P01 HL048675
6 · The paper itself

Abstract

Despite extensive evidence that integrin conformational changes between bent and extended conformations regulate affinity for ligands, an alternative hypothesis has been proposed in which a "deadbolt" can regulate affinity for ligand in the absence of extension. Here, we tested both the deadbolt and the extension models. According to the deadbolt model, a hairpin loop in the beta3 tail domain could act as a deadbolt to restrain the displacement of the beta3 I domain beta6-alpha7 loop and maintain integrin in the low affinity state. We found that mutating or deleting the beta3 tail domain loop has no effect on ligand binding by either alphaIIbbeta 3 or alphaVbeta3 integrins. In contrast, we found that mutations that lock integrins in the bent conformation with disulfide bonds resist inside-out activation induced by cytoplasmic domain mutation. Furthermore, we demonstrated that extension is required for accessibility to fibronectin but not smaller fragments. The data demonstrate that integrin extension is required for ligand binding during integrin inside-out signaling and that the deadbolt does not regulate integrin activation.

Indexed as

AnimalsCell MembraneCHO CellsCricetinaeCricetulusFibronectinsHumansIntegrin alphaVIntegrin beta3IntegrinsLigandsMutationPlatelet Membrane Glycoprotein IIbProtein BindingProtein Structure, TertiaryFibronectinsIntegrin alphaVIntegrin beta3IntegrinsLigandsPlatelet Membrane Glycoprotein IIb

Identifiers

PMID17301049
PMCPMC1952534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.